Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about REELIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Comprehensive page on Reelin - structure, function, role in neuronal migration, synaptic plasticity, and Alzheimer's disease
No AI portrait yet
| Gene Symbol | RELN |
| Aliases | Comprehensive page on Reelin |
| Chromosome | 7q22.1 |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Molecular Weight | 388 kDa |
| Amino Acids | 460 aa |
| Pathways | Dendritic Spine |
| UniProt ID | P78536 |
| NCBI Gene ID | 5649 |
| GeneCards | RELN |
| Human Protein Atlas | RELN |
| Associated Diseases | Aging, Als, Alzheimer, Alzheimer's disease |
| Interactions | ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID, AND, APOE3, APOER2 |
| KG Connections | 318 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
REELIN["REELIN"] -->|"causes"| ALS["ALS"]
REELIN["REELIN"] -.->|"inhibits"| ALS_1["ALS"]
REELIN["REELIN"] -.->|"inhibits"| Alzheimer["Alzheimer"]
REELIN["REELIN"] -->|"regulates"| ALS_2["ALS"]
REELIN["REELIN"] -->|"associated"| Alzheimer_3["Alzheimer"]
REELIN["REELIN"] -->|"associated"| Autism["Autism"]
CDK5["CDK5"] -->|"causes"| REELIN["REELIN"]
AXON["AXON"] -->|"causes"| REELIN["REELIN"]
LIS1["LIS1"] -->|"causes"| REELIN["REELIN"]
NEURON["NEURON"] -->|"causes"| REELIN["REELIN"]
style REELIN fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| synaptogenesis | regulates | biological_process | 0.90 |
| Neuronal Migration | regulates | biological_process | 0.90 |
| Dendritic Spine Formation | regulates | biological_process | 0.90 |
| ApoER2 | binds_to | protein | 0.90 |
| Synaptic Plasticity | regulates | biological_process | 0.90 |
| Dendritic Growth And Branching | regulates | biological_process | 0.90 |
| neuronal migration | regulates | process | 0.90 |
| NEURONAL MIGRATION | regulates | entity | 0.90 |
| synaptic plasticity | regulates | process | 0.90 |
| dendritic growth and branching | regulates | process | 0.90 |
| dendritic spine formation | regulates | process | 0.90 |
| synaptogenesis | regulates | process | 0.90 |
| Apoer2 | binds | receptor | 0.90 |
| NF-κB | phosphorylates | protein | 0.85 |
| Nmda Receptor | activates | receptor | 0.85 |
| Heart Development | regulates | process | 0.85 |
| Injury Repair | regulates | process | 0.85 |
| AKT | phosphorylates | protein | 0.85 |
| platelet adhesion | promotes | process | 0.85 |
| PI3K | phosphorylates | protein | 0.85 |
| DEPRESSION | associated_with | disease | 0.80 |
| PI3K | activates | protein | 0.80 |
| AKT | activates | protein | 0.80 |
| mental retardation | implicated_in | disease | 0.80 |
| Alzheimer's disease | implicated_in | disease | 0.80 |
| Alzheimer's disease | associated_with | disease | 0.80 |
| lissencephaly | implicated_in | disease | 0.80 |
| AUTISM | implicated_in | disease | 0.80 |
| schizophrenia | implicated_in | disease | 0.80 |
| bipolar disorder | implicated_in | disease | 0.80 |
| Injury Repair | involved_in | process | 0.75 |
| Heart Development | involved_in | process | 0.75 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Addiction | therapeutic_target | disease | 0.65 |
| Depression | activates | disease | 0.65 |
| Traumatic Brain Injury | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Schizophrenia | associated_with | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Ms | interacts_with | disease | 0.65 |
| Alzheimer | protects_against | disease | 0.65 |
| Depression | associated_with | disease | 0.65 |
| Dementia | therapeutic_target | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Autism | associated_with | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Epilepsy | associated_with | disease | 0.65 |
| ALS | causes | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| DAB1 | interacts_with | entity | 0.85 |
| VE-cadherin | regulates | protein | 0.80 |
| APP | associated_with | gene | 0.75 |
| ApoE | interacts_with | gene | 0.70 |
| NEURODEGENERATION | activates | gene | 0.60 |
| FGF | activates | gene | 0.60 |
| BRAIN INJURY | activates | gene | 0.60 |
| AXON | activates | gene | 0.60 |
| NEURON | activates | gene | 0.60 |
| EPILEPSY | mediates | entity | 0.60 |
| STROKE | associated_with | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| AUTISM | mediates | entity | 0.60 |
| DEPRESSION | mediates | entity | 0.60 |
| SYNAPSE | activates | gene | 0.60 |
| NEURON | therapeutic_target | gene | 0.60 |
| APOER2 | protects_against | gene | 0.60 |
| STROKE | therapeutic_target | gene | 0.60 |
| IL-6 | therapeutic_target | gene | 0.60 |
| DEPRESSION | therapeutic_target | gene | 0.60 |
| PARKINSON | therapeutic_target | gene | 0.60 |
| EPILEPSY | therapeutic_target | gene | 0.60 |
| ARF6 | interacts_with | gene | 0.60 |
| APOE | interacts_with | gene | 0.60 |
| DCX | causes | gene | 0.60 |
| PAFAH1B1 | causes | gene | 0.60 |
| CDK5 | causes | gene | 0.60 |
| LIS1 | causes | gene | 0.60 |
| CD2AP | protects_against | entity | 0.60 |
| APOE | therapeutic_target | entity | 0.60 |
| LISSENCEPHALY | associated_with | entity | 0.60 |
| LISSENCEPHALY | mediates | entity | 0.60 |
| APOE | protects_against | gene | 0.60 |
| APP | regulates | gene | 0.60 |
| LDL | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| DYNEIN | causes | gene | 0.60 |
| DAB1 | causes | gene | 0.60 |
| REST | activates | gene | 0.60 |
| CD2AP | activates | gene | 0.60 |
| JUN | protects_against | gene | 0.60 |
| APOE | associated_with | gene | 0.60 |
| RELN | protects_against | gene | 0.60 |
| FYN | associated_with | gene | 0.60 |
| JUN | regulates | gene | 0.60 |
| SRC | associated_with | gene | 0.60 |
| DAB1 | associated_with | gene | 0.60 |
| LDLR | associated_with | gene | 0.60 |
| LRP4 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Reelin-Mediated Cytoskeletal Stabilization Protocol | 0.689 | neurodegeneration | Selective vulnerability of entorhinal co |
| H3: Reelin Signaling Deficiency Uncouples Layer II Neurons f | 0.560 | neurodegeneration | Entorhinal cortex layer II vulnerability |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| REL transcription factor mediates VLC ceramide-driven inflammation | exploratory | inflammation | 0.750 | 0.00 | innate immune cells | proposed | N/A |
| Levodopa Response Determinants in PSP — Biomarker-Guided Prediction St | clinical | Neurodegeneration | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Neural Stem Cell Therapy for Alzheimer's Disease | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Loss of endothelial CD2AP causes sex-dependent cerebrovascular dysfunction. [PMID:39892386] | Vandal M, Institoris A, Reveret L, Korin | Neuron | 2025 | 1 |
| Protective genetic variants against Alzheimer's disease. [PMID:40409316] | Marino C, Malotaux V, Giudicessi A, Agui | Lancet Neurol | 2025 | 1 |
| Proximity interactome of lymphatic VE-cadherin reveals mechanisms of junctional [PMID:39232006] | Serafin DS, Harris NR, Bálint L, Douglas | Nat Commun | 2024 | 1 |
| Reelin Functions, Mechanisms of Action and Signaling Pathways During Brain Devel [PMID:32604886] | Jossin Y | Biomolecules | 2020 | 1 |
| Neuronal migration. [PMID:11429281] | Lambert de Rouvroit C, Goffinet AM | Mech Dev | 2001 | 1 |
| Modulation of apolipoprotein E receptor-2 by ApoE4, amyloid β-peptide, reelin, a [PMID:41858499] | ["Barger S", "Moerman-Herzog A"] | Frontiers in molecular neurosc | 2026 | 0 |
| The Potential Molecular Mechanisms and Key Genes of Early Deterioration of Paren [PMID:41863408] | ["Cen G", "Li J", "Wang J", "Chen Y", "L | Current neurovascular research | 2026 | 0 |
| RELN biallelic variant as a candidate risk factor in a consanguineous Pakistani [PMID:41785923] | ["Hashmi A", "Harripaul R", "Muhammad T" | Journal of affective disorders | 2026 | 0 |
| Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, [PMID:41893052] | Burdman Gabriel; Akkaoui Juliet; Colon N | Neurology international | 2026 | 0 |
| Temporal and Spatial Gene Expression Dynamics in Neonatal HI Hippocampus with Fo [PMID:41677619] | ["Smith M", "Natarajan E", "Lizama-Valen | Cells | 2026 | 0 |
| Migration of dI5 Reelin-Lmx1b-Zfhx3 and Disabled-1-Lmx1b-Zfhx3 neurons contribut [PMID:41890024] | ["Yvone G", "Chavez-Martinez C", "Mekonn | bioRxiv : the preprint server | 2026 | 0 |
| Whisking Behaviour Reveals Stronger Evidence of Habituation in Homozygous Reeler [PMID:41844513] | ["Simanaviciute U", "Cetin A", "Guy J", | Genes, brain, and behavior | 2026 | 0 |
| Reln haploinsufficiency enhances fentanyl-induced locomotion and striatal activi [PMID:41890027] | ["Litif C", "Libster A", "Desfor S", "Hu | bioRxiv : the preprint server | 2026 | 0 |
| Immunoglobulin allotypes and [PMID:41848375] | ["Pandey J", "Namboodiri A", "Nietert P" | Journal of Alzheimer's disease | 2026 | 0 |
| Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, [PMID:41893052] | ["Burdman G", "Akkaoui J", "Colon N", "P | Neurology international | 2026 | 0 |
| Genetic or therapeutic disruption of the Reelin/Apoer2 signaling pathway improve [PMID:40073057] | ["Calvier L", "Wasser C", "Solow E", "Wu | Proceedings of the National Ac | 2025 | 0 |
| Molecular hallmarks of excitatory and inhibitory neuronal resilience to Alzheime [PMID:41035073] | Castanho I, Naderi Yeganeh P, Boix CA, M | Molecular neurodegeneration | 2025 | 0 |
| Glutamatergic argonaute2 promotes the formation of the neurovascular unit in mic [PMID:39999211] | Sona C, Yeh YT, Li Y, Liu X, Ghosh A, Hi | Science signaling | 2025 | 0 |
| APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodege [PMID:40307424] | ["Vanherle S", "Janssen A", "Guti\u00e9r | Molecular psychiatry | 2025 | 0 |
| Protective Genes Against Alzheimer's Disease: Case Review and Therapeutic Implic [PMID:40321438] | Hossain N, Jeong Y | Dementia and neurocognitive di | 2025 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning REELIN in their description or question text
No additional research found